Targeting Drug Conjugates to the Tumor Microenvironment: Probody Drug Conjugates

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. Today, we are talking about probody drug conjugates, a drug targeting conjugate to the tumor microenvironment. If you want to learn more information about ADC, please follow us.